Executive Management Team

 

 
Graham Mullis
Chief Executive Officer

 

  • Joined Lab21 January 2008
  • Over 25 years in healthcare; pharmaceuticals & medical devices
  • Internationally experienced leader with multi-disciplinary background
  • Both public (FTSE 250 & NASDAQ) and private companies
  • Experienced in M&A activity and MBO
  • Lived & worked in US and Singapore
 
Eric Peltier
Chief Innovation Officer

 

  • Founder of NOVACYT July 2006
  • Over 25 years in healthcare; IVD field & medical devices
  • Internationally experienced leader with multi-disciplinary background
  • Experienced in R&D and innovation with more than 100 patents
 
Jean-Pierre Crinelli
Group Operations Director

 

  • Based in Paris
 
Anthony Dyer
Finance Director

 

  • Joined Lab21 January 2010
  • 15 years in healthcare; pharmaceuticals & medical devices
  • Experienced in dynamic growth businesses and M&A
  • Both public (AIM, Euronext, NASDAQ & NYSE) and private
    companies
  • FCCA qualified 17 years; commercial and audit background
  • Healthcare background in start-ups, small cap and multi-national
    CRO
 
Ian Wilde
Head of Quality Assurance & Regulatory Compliance

 

  • Joined Novacyt in October 2014
  • Over 15 years experience in medical devices
  • Extensive experience at Senior Management and Board level
  • Experience in both SME’s and Blue Chip organisations
  • Strong experience in Quality System development and Regulatory Compliance
 
Manuela Gazzard
Commercial Director

 

  • Joined Novacyt in March 2015
  • 18 years of healthcare experience with blue chip organisations such as Johnson& Johnson as well as Biotech companies
  • IPO experienced
  • Led many M&A projects and launched several blockbuster products globally
  • Won international industry awards for setting commercial standards in Pharma
  • Experienced leader with leadership degree from University of Cape Town
  • Originally from Germany and a scientist by training with a doctorate in cancer research